Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69 | 181 | 188 | 141 | 167 |
| Receivables | 99 | 0 | 0 | 51 | 51 |
| TOTAL | $169 | $181 | $188 | $193 | $218 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $169 | $181 | $188 | $193 | $218 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8 | 14 | 11 | 4 | 0 |
| Accrued Expenses | 7 | 7 | 2 | 2 | 8 |
| TOTAL | $14 | $20 | $13 | $7 | $8 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | -1 | 0 | 0 |
| TOTAL | $0 | $0 | $-1 | $0 | $0 |
| Total Liabilities | $14 | $20 | $12 | $7 | $8 |
| Shareholders' Equity | |||||
| Common Shares | 294 | 294 | 294 | 294 | 294 |
| Retained earnings | -241 | -234 | -219 | -209 | -186 |
| Other shareholders' equity | 101 | 101 | 101 | 101 | 101 |
| TOTAL | $155 | $161 | $176 | $186 | $209 |
| Total Liabilities And Equity | $169 | $181 | $188 | $193 | $218 |